Frontier Biotechnologies Inc. Class ASSE: 688221

Report for Q3 2024

Oct 31, 2024 · Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment